Brought to you by 
Spark Therapeutics nets $172mm in initial public offering
05 Feb 2015
Executive Summary
Gene therapy company Spark Therapeutics LLC netted $172mm in its initial public offering of 8.1mm shares (including the overallotment) for $23. Both the number of shares and price were upsized from planned terms: earlier this month Spark said it would sell 5.5mm shares for $15-17, and the company later amended that to 6.5mm shares at $19-21.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
- Site Specific
-
Drug Delivery
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Spark Therapeutics nets $172mm in initial public offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice